Global Regenerative Medicines Market is expected to grow at a CAGR of 24.2% from 2017 to 2025.

Portland, OR -- (SBWire) -- 07/19/2017 --Global Regenerative Medicines Market is expected to grow at a CAGR of 24.2% from 2017 to 2025. Regenerative medicines have the potential to heal damaged tissues and organs, completely. In this process, specific types of cells or cell products are delivered to diseased tissues or organs, where they ultimately restore tissue and organ function. This can be done through cell-based therapy or by using cell products, such as growth factors.

Request Sample At: https://www.progressivemarkets.com/industry-research/regenerative-medicines-market

Based on type, the Regenerative Medicines Market is segmented as tissue engineering, cell therapy, small molecules & biologics, and gene therapy. By material, the market is divided into synthetic materials, genetically engineered materials, pharmaceuticals, and biologically derived materials. By application, the market is classified as cardiovascular, ophthalmology, dermatology, musculoskeletal, wound healing, oncology, neurology, and others. Geographically, it is studied across North America, Europe, Asia-Pacific, and LAMEA.

Regenerative Medicines Market Dynamics:

Drivers:

Advancements in technology for tissue and organ regeneration.
Increase in prevalence of chronic diseases.
Rise in government and private funding for the development of regenerative medicines.
Growth in geriatric population.
Restraints:

High cost of regenerative medicines.
Stringent governmental regulations.
Regenerative Medicines Market Players:

Enquire About Report At: https://www.progressivemarkets.com/enquiry-about-report/regenerative-medicines-market

The top players in the global regenerative medicines market include Zimmer Biomet Holdings, Inc., Medtronic plc, Stryker Corporation, Ocata Therapeutics, Inc., Baxter International, Inc., DePuy Synthes, Organogenesis, Inc., Integra Lifesciences Holdings Corporation, Acelity Holdings, Inc., and CryoLife, Inc.

MARKET LANDSCAPE

By Type

Tissue Engineering
Cell Therapy
Small Molecules & Biologics
Gene Therapy
By Material

Synthetic Materials
Biodegradable Synthetic Polymers
Hydrogel Material
Scaffold
Artificial Vascular Graft Materials

By Application

Cardiovascular
Ophthalmology
Dermatology
Musculoskeletal
Wound Healing

By Geography
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Spain
Italy
Rest of Europe

Request Customization at: https://www.progressivemarkets.com/request-customization/regenerative-medicines-market

Table Of Contents:
1. Executive summary
1.1. Key findings
1.2. Market attractiveness and trend analysis
1.3. Competitive landscape and recent industry development analysis
2. Introduction
2.1. Report description
2.2. Scope and definitions
2.3. Research methodology
3. Market landscape
3.1. Growth drivers
3.1.1. Impact analysis
3.2. Restrains and challenges
4. Global regenerative medicines market by type
4.1. Tissue engineering
4.1.1. Historical market size by region, 2014-2016
4.1.2. Market forecast by region, 2017-2025
4.2. Cell therapy
5. Global regenerative medicines market by material
5.1. Synthetic materials
5.1.1. Historical market size by region, 2014-2016
5.1.2. Market forecast by region, 2017-2025